Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01883258 · ClinicalTrials.gov registry record · NA
Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes
A NA study of Type 2 Diabetes, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT01883258: Completed NA study of Type 2 Diabetes, sponsored by University of Florida.
NCT01883258 is a NA study of Type 2 Diabetes that has completed, run by University of Florida. The registered enrollment target is 116 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01883258, a NA study of Type 2 Diabetes, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
The study objectives are: 1. To compare cardiovascular function in type 2 diabetes patients vs. healthy controls. 2. To compare the effect of 8 weeks of aerobic interval training versus continuous moderate exercise on cardiovascular function in adults with type 2 diabetes. 3. To examine the mechanisms underlying the exercise-related changes in cardiovascular function. The investigators hypothesize that compared to continuous moderate intensity exercise training, interval training will be more effective in improving cardiovascular function in adults with type 2 diabetes.
Primary Outcome
Brachial flow mediated dilation using ultrasonography
Conditions Studied
Interventions
- OTHER High intensity aerobic interval training
- OTHER Continuous moderate intensity exercise
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2013-05 |
| Est. Completion | 2018-07-16 |
| Phase | NA |
What the finished NCT01883258 record still lists
NCT01883258 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which High intensity aerobic interval training is the first listed.
NCT01883258 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01883258 about?
NCT01883258 is a clinical study titled "Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes". The study objectives are: 1. To compare cardiovascular function in type 2 diabetes patients vs. healthy controls. 2. To compare the effect of 8 weeks of aerobic interval training versus continuous moderate exercise on cardiovascular function in adults with type 2 diabetes. 3. To examine the mechani...
What is the current status of trial NCT01883258?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2013-05. Estimated completion is 2018-07-16.
What conditions does trial NCT01883258 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
What interventions are being tested in trial NCT01883258?
The interventions under investigation include: High intensity aerobic interval training (OTHER), Continuous moderate intensity exercise (OTHER).
Who is sponsoring clinical trial NCT01883258?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01883258 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01883258's enrollment target sits among peer trials
116 138th of 327 higher than 189 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia